Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Crutchfield Dermatology Announces a New Platelet Rich Plasma Combination Treatment for Hair Loss

Crutchfield Dermatology Announces the Successful Treatment of Hair Loss using a Novel combination of Platelet Rich Plasma, Prostaglandins, Botox, Lasers, Essential Oils, Minoxidil, Finasteride, and Scalp Conditioning Treatments.


News provided by

Crutchfield Dermatology

Jun 25, 2020, 21:15 ET

Share this article

Share toX

Share this article

Share toX

Charles E. Crutchfield III, M.D.
Charles E. Crutchfield III, M.D.

EAGAN, Minn., June 25, 2020 /PRNewswire-PRWeb/ -- Crutchfield Dermatology Announces the Successful Treatment of Hair Loss using a Novel combination of Platelet Rich Plasma, Prostaglandins, Botox, Lasers, Essential Oils, Minoxidil, Finasteride, and Scalp Conditioning Treatments.

Charles Crutchfield III M.D., a nationally recognized Board Certified Dermatologist and Clinical Professor of Dermatology, has developed a new and successful system to treat alopecia using Platelet Rich Plasma (PRP) therapy, in conjunction with several other leading-edge modalities for the treatment of hair loss and thinning hair.

"In our experience, although PRP and some of the other components are not yet FDA approved for Alopecia, we have a success rate of approximately 75% with our designer hair growth program. " - Charles E. Crutchfield III, M.D.

Post this

As a non-surgical medical procedure to treat hair loss and thinning hair, PRP Therapy has been a well recognized successful treatment over the past several years. Charles E. Crutchfield III M.D. has seen significant results in patients seeking treatment for hair loss (Alopecia). "Using the patient's own blood, we create a concentration of Platelet Rich Plasma to promote hair growth and rejuvenation." Charles E. Crutchfield III M.D. explains the treatment and its benefits: "PRP therapy uses the patient's blood to create the ideal formula of Platelet Rich Plasma. We start by drawing a blood sample and spinning the blood to separate its components: red blood cells, plasma, and platelet-rich plasma. Injecting the enriched platelet-rich plasma (containing concentrated amounts of growth factors, cytokines, and platelets), into the treatment area. This PRP treatment stimulates the inactive hair follicles into an active growth phase."

"In addition to using PRP, we also treat the hair loss with a combination of other modalities that work synergistically. It is not "one size fits all". We have developed a custom design a program for the patient for their maximum hair growth programs.

Crutchfield uses a combination of the following for maximal hair growth:

  •     Platelet Rich Plasma (PRP)
  •     Crutchfield Dermatology Hair Tonic (containing prostaglandins, finasteride, and minoxidil)
  •     Botox injections
  •     Hair Growth Vitamins and minerals
  •     Essential Oils that promote hair growth
  •     Keravive scalp conditioning treatments
  •     Laser treatments for hair growth
  •     Anti-inflammatory Scalp Program

We find that this combination of treatments works better than anything that we have tried in the past and we are stull refining the components.

Dr. Crutchfield has seen a significant increase in the number of patients inquiring about this therapy. Estimates are that nearly 100 million Americans suffer from hair loss. PRP for Hair Loss Therapy and the additional program of other modalities developed at Crutchfield Dermatology is a breakthrough treatment option because it is a safe, reliable treatment that is short and non-surgical. The recovery period is fast, and the results are natural.

"In our experience, although PRP and some of the other components are not yet FDA approved for Alopecia, we have a success rate of approximately 75% with our designer hair growth program.

I recommend a series of injections to be done monthly, for 4-6 months and our other programs. Once patients achieve the level of hair regrowth they are happy with, we recommend a topical treatment program to maintain and extend the PRP treatment success and recommend a PRP treatment every 6 or 12 months for maintenance. "

The hair loss and hair thinning treatment program with PRP and the other components works well for both men and women. It is primarily designed to treat androgenetic Alopecia, but we have had success in alopecia areata, scarring alopecia, and hair loss associated with stress (telogen effluvium), also.

As the testing continues and the components are adjusted, we will submit a report.

About Charles E. Crutchfield III, M.D:
Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He is currently the Medical Director of Crutchfield Dermatology in Eagan and is a Benedict Distinguished Professor of Biology at Carleton College. Dr. Crutchfield has won numerous teaching and professional awards and is the co-author of a children's book on sun protection, a dermatology textbook, and hundreds of medial articles. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. He is the team physician for the Minnesota Twins, Vikings, Wild, Timberwolves and Lynx professional sports teams. Dr. Crutchfield has over 25 years of clinical experience caring for patients.

SOURCE Crutchfield Dermatology

Related Links

http://www.crutchfielddermatology.com

Modal title

Before and after photos after treatments with PRP.
Before and after photos after treatments with PRP.
Plasma Rich Protein Cells
Plasma Rich Protein Cells
Before and after photos after treatments with PRP. Plasma Rich Protein Cells

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.